Loading...
Marijuana Company of America, Inc.
MCOA•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$-0.00(-99.00%)
U.S. Market opens in 23h 50mMarijuana Company of America, Inc. (MCOA) AI-Powered Stock Analysis
See how Marijuana Company of America, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMarijuana Company of America, Inc. (MCOA) Stock Overall Grade
Marijuana Company of America, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Marijuana Company of America, Inc.'s overall stock rating.
Forecast
C+Score
53/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
B+Score
70/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100Marijuana Company of America, Inc. (MCOA) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 53/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (70/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Marijuana Company of America, Inc. stock grade, including financials, comparisons, and forecasts.